Global Implantable Neurostimulators Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Implantable Neurostimulators Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

According to APO Research, The global Implantable Neurostimulators market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Implantable Neurostimulators is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Implantable Neurostimulators include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences and ElectroCore Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Implantable Neurostimulators, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Implantable Neurostimulators, also provides the sales of main regions and countries. Of the upcoming market potential for Implantable Neurostimulators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Implantable Neurostimulators sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Implantable Neurostimulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Implantable Neurostimulators sales, projected growth trends, production technology, application and end-user industry.

Implantable Neurostimulators segment by Company

Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO
Implantable Neurostimulators segment by Type

Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others
Implantable Neurostimulators segment by Application

Parkinson's Disease
Epilepsy
Pain
Others
Implantable Neurostimulators segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Implantable Neurostimulators status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Implantable Neurostimulators market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Implantable Neurostimulators significant trends, drivers, influence factors in global and regions.
6. To analyze Implantable Neurostimulators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Neurostimulators market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Implantable Neurostimulators industry.
Chapter 3: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Implantable Neurostimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Implantable Neurostimulators in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Implantable Neurostimulators Sales Value (2019-2030)
1.2.2 Global Implantable Neurostimulators Sales Volume (2019-2030)
1.2.3 Global Implantable Neurostimulators Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Implantable Neurostimulators Market Dynamics
2.1 Implantable Neurostimulators Industry Trends
2.2 Implantable Neurostimulators Industry Drivers
2.3 Implantable Neurostimulators Industry Opportunities and Challenges
2.4 Implantable Neurostimulators Industry Restraints
3 Implantable Neurostimulators Market by Company
3.1 Global Implantable Neurostimulators Company Revenue Ranking in 2023
3.2 Global Implantable Neurostimulators Revenue by Company (2019-2024)
3.3 Global Implantable Neurostimulators Sales Volume by Company (2019-2024)
3.4 Global Implantable Neurostimulators Average Price by Company (2019-2024)
3.5 Global Implantable Neurostimulators Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Implantable Neurostimulators Company Manufacturing Base & Headquarters
3.7 Global Implantable Neurostimulators Company, Product Type & Application
3.8 Global Implantable Neurostimulators Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Implantable Neurostimulators Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Implantable Neurostimulators Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Implantable Neurostimulators Market by Type
4.1 Implantable Neurostimulators Type Introduction
4.1.1 Deep Brain Stimulators
4.1.2 Spinal Cord Stimulators
4.1.3 Vagal Nerve Stimulators
4.1.4 Sacral Nerve Stimulators
4.1.5 Gastric Stimulators
4.1.6 Others
4.2 Global Implantable Neurostimulators Sales Volume by Type
4.2.1 Global Implantable Neurostimulators Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Implantable Neurostimulators Sales Volume by Type (2019-2030)
4.2.3 Global Implantable Neurostimulators Sales Volume Share by Type (2019-2030)
4.3 Global Implantable Neurostimulators Sales Value by Type
4.3.1 Global Implantable Neurostimulators Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Implantable Neurostimulators Sales Value by Type (2019-2030)
4.3.3 Global Implantable Neurostimulators Sales Value Share by Type (2019-2030)
5 Implantable Neurostimulators Market by Application
5.1 Implantable Neurostimulators Application Introduction
5.1.1 Parkinson's Disease
5.1.2 Epilepsy
5.1.3 Pain
5.1.4 Others
5.2 Global Implantable Neurostimulators Sales Volume by Application
5.2.1 Global Implantable Neurostimulators Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Implantable Neurostimulators Sales Volume by Application (2019-2030)
5.2.3 Global Implantable Neurostimulators Sales Volume Share by Application (2019-2030)
5.3 Global Implantable Neurostimulators Sales Value by Application
5.3.1 Global Implantable Neurostimulators Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Implantable Neurostimulators Sales Value by Application (2019-2030)
5.3.3 Global Implantable Neurostimulators Sales Value Share by Application (2019-2030)
6 Implantable Neurostimulators Market by Region
6.1 Global Implantable Neurostimulators Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Implantable Neurostimulators Sales by Region (2019-2030)
6.2.1 Global Implantable Neurostimulators Sales by Region: 2019-2024
6.2.2 Global Implantable Neurostimulators Sales by Region (2025-2030)
6.3 Global Implantable Neurostimulators Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Implantable Neurostimulators Sales Value by Region (2019-2030)
6.4.1 Global Implantable Neurostimulators Sales Value by Region: 2019-2024
6.4.2 Global Implantable Neurostimulators Sales Value by Region (2025-2030)
6.5 Global Implantable Neurostimulators Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Implantable Neurostimulators Sales Value (2019-2030)
6.6.2 North America Implantable Neurostimulators Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Implantable Neurostimulators Sales Value (2019-2030)
6.7.2 Europe Implantable Neurostimulators Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Implantable Neurostimulators Sales Value (2019-2030)
6.8.2 Asia-Pacific Implantable Neurostimulators Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Implantable Neurostimulators Sales Value (2019-2030)
6.9.2 Latin America Implantable Neurostimulators Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Implantable Neurostimulators Sales Value (2019-2030)
6.10.2 Middle East & Africa Implantable Neurostimulators Sales Value Share by Country, 2023 VS 2030
7 Implantable Neurostimulators Market by Country
7.1 Global Implantable Neurostimulators Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Implantable Neurostimulators Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Implantable Neurostimulators Sales by Country (2019-2030)
7.3.1 Global Implantable Neurostimulators Sales by Country (2019-2024)
7.3.2 Global Implantable Neurostimulators Sales by Country (2025-2030)
7.4 Global Implantable Neurostimulators Sales Value by Country (2019-2030)
7.4.1 Global Implantable Neurostimulators Sales Value by Country (2019-2024)
7.4.2 Global Implantable Neurostimulators Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.5.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.6.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.7.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.8.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.9.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.10.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.11.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.12.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.13.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.14.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.15.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.16.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.17.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.18.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.19.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.20.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.21.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.22.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Implantable Neurostimulators Sales Value Growth Rate (2019-2030)
7.23.2 Global Implantable Neurostimulators Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Implantable Neurostimulators Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Medtronic
8.1.1 Medtronic Comapny Information
8.1.2 Medtronic Business Overview
8.1.3 Medtronic Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.1.4 Medtronic Implantable Neurostimulators Product Portfolio
8.1.5 Medtronic Recent Developments
8.2 Boston Scientific
8.2.1 Boston Scientific Comapny Information
8.2.2 Boston Scientific Business Overview
8.2.3 Boston Scientific Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
8.2.5 Boston Scientific Recent Developments
8.3 St. Jude Medical
8.3.1 St. Jude Medical Comapny Information
8.3.2 St. Jude Medical Business Overview
8.3.3 St. Jude Medical Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
8.3.5 St. Jude Medical Recent Developments
8.4 Cyberonics
8.4.1 Cyberonics Comapny Information
8.4.2 Cyberonics Business Overview
8.4.3 Cyberonics Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
8.4.5 Cyberonics Recent Developments
8.5 NeuroPace
8.5.1 NeuroPace Comapny Information
8.5.2 NeuroPace Business Overview
8.5.3 NeuroPace Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
8.5.5 NeuroPace Recent Developments
8.6 Synapse Biomedical
8.6.1 Synapse Biomedical Comapny Information
8.6.2 Synapse Biomedical Business Overview
8.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
8.6.5 Synapse Biomedical Recent Developments
8.7 NeuroSigma
8.7.1 NeuroSigma Comapny Information
8.7.2 NeuroSigma Business Overview
8.7.3 NeuroSigma Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.7.4 NeuroSigma Implantable Neurostimulators Product Portfolio
8.7.5 NeuroSigma Recent Developments
8.8 ReShape Lifesciences
8.8.1 ReShape Lifesciences Comapny Information
8.8.2 ReShape Lifesciences Business Overview
8.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
8.8.5 ReShape Lifesciences Recent Developments
8.9 ElectroCore Medical
8.9.1 ElectroCore Medical Comapny Information
8.9.2 ElectroCore Medical Business Overview
8.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
8.9.5 ElectroCore Medical Recent Developments
8.10 Inspire Medical
8.10.1 Inspire Medical Comapny Information
8.10.2 Inspire Medical Business Overview
8.10.3 Inspire Medical Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
8.10.5 Inspire Medical Recent Developments
8.11 NEUROS
8.11.1 NEUROS Comapny Information
8.11.2 NEUROS Business Overview
8.11.3 NEUROS Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.11.4 NEUROS Implantable Neurostimulators Product Portfolio
8.11.5 NEUROS Recent Developments
8.12 SPR
8.12.1 SPR Comapny Information
8.12.2 SPR Business Overview
8.12.3 SPR Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.12.4 SPR Implantable Neurostimulators Product Portfolio
8.12.5 SPR Recent Developments
8.13 IMTHERA
8.13.1 IMTHERA Comapny Information
8.13.2 IMTHERA Business Overview
8.13.3 IMTHERA Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
8.13.5 IMTHERA Recent Developments
8.14 NEVRO
8.14.1 NEVRO Comapny Information
8.14.2 NEVRO Business Overview
8.14.3 NEVRO Implantable Neurostimulators Sales, Value and Gross Margin (2019-2024)
8.14.4 NEVRO Implantable Neurostimulators Product Portfolio
8.14.5 NEVRO Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Implantable Neurostimulators Value Chain Analysis
9.1.1 Implantable Neurostimulators Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Implantable Neurostimulators Sales Mode & Process
9.2 Implantable Neurostimulators Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Implantable Neurostimulators Distributors
9.2.3 Implantable Neurostimulators Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings